Nanexa AB announces that the phase I study with NEX-22, the company's one-month formulation of liraglutide, will resume with further dose escalation with an expected start in the first quarter of 2025 ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

Victoza is another injectable GLP-1 medication ... but in a slightly higher dose. However, unlike Ozempic, Wegovy is FDA approved for weight management in adults with overweight and obesity ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Victoza is the first and (as of December 2024) only GLP-1 agonist available as a generic. Administration and Dosage All GLP-1 agonists, including Victoza and Ozempic, are given by subcutaneous (under ...

Some dosage strengths of both Victoza and Saxenda are included on the FDA's shortages list, mainly due to pressures on Novo Nordisk's production capacity for its entire GLP-1 franchise ...